Lipotoxicity: a driver of heart failure with preserved ejection fraction?
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a growing public health concern, with rising incidence alongside high morbidity and mortality. However, the pathophysiology of HFpEF is not yet fully understood. The association between HFpEF and the metabolic syndrome (MetS) suggests that dysregulated lipid metabolism could drive diastolic dysfunction and subsequent HFpEF. Herein we summarise recent advances regarding the pathogenesis of HFpEF in the context of MetS, with a focus on impaired lipid handling, myocardial lipid accumulation and subsequent lipotoxicity.
Description
Keywords
diastolic dysfunction, heart failure with preserved ejection fraction, lipid metabolism, lipotoxicity, metabolic syndrome
Journal Title
Clinical science (London, England : 1979)
Conference Name
Journal ISSN
0143-5221
1470-8736
1470-8736
Volume Title
135
Publisher
Portland Press
Publisher DOI
Sponsorship
Medical Research Council (MC_UU_12012/2)
British Heart Foundation (RG/18/7/33636)
British Heart Foundation (FS/17/61/33473D)
British Heart Foundation (RE/18/1/34212)
Medical Research Council (G0802051)
Medical Research Council (G0400192)
British Heart Foundation (None)
Medical Research Council (MC_UU_12012/5)
MRC (MC_UU_00014/2)
Medical Research Council (MC_PC_12012)
British Heart Foundation (RG/18/7/33636)
British Heart Foundation (FS/17/61/33473D)
British Heart Foundation (RE/18/1/34212)
Medical Research Council (G0802051)
Medical Research Council (G0400192)
British Heart Foundation (None)
Medical Research Council (MC_UU_12012/5)
MRC (MC_UU_00014/2)
Medical Research Council (MC_PC_12012)
We thank the British Heart Foundation [grant numbers RG/18/7/33636 and FS/17/61/33473]; the Cambridge BHF Centre of Research Excellence [grant number RE/18/1/34212]; and the Medical Research Council [grant number MC UU 12012/2] for funding this work.